VAK-therapy as a variant of local treatment of destructive forms of erysipelas
DOI:
https://doi.org/10.34287/MMT.4(51).2021.7Abstract
Purpose of the study. Improve postoperative treatment of phlegmonous and necrotic forms of erysipelas by alternating HAC therapy of wounds and staged necrectomies, reduce the time of cleaning and preparation of the wound for dermatoplasty.
Materials and metods. The results of treatment of 87 patients with complicated forms of erysipelas who were treated in the purulent-septic center of KNP «City Hospital № 3» in Zaporozhye for the period 2020–2021 were analyzed.
Results. The effectiveness of treatment, including topical therapy, was evaluated by improving laboratory parameters (leukocyte formula), the number of microbial bodies per 1g of tissue and the duration of wound cleansing. In the phlegmonous form of erysipelas, normalization of the leukocyte formula was observed on day 3, which is probably faster than among patients in the control group – on day 4 (t = 4,01375; P = 0,000182). In patients with necrotic form of erysipelas in the main group, the normalization of the leukocyte formula occurred probably faster, almost 2 days, than in the control group – 4 and 6 days, respectively (t = 2,16682; P = 0,042499). At the same time there was a decrease in microbial contamination of wounds. The terms of wound cleansing in the postoperative period in patients of the main group were probably shorter than in patients of the control group – by 1,87 ± 0,23 days in phlegmonous form (t = 3,75213; P = 0,000320) and 2,89 ± 0,34 in necrotic (t = 2,33969; P = 0,026659).
Conclusion. Improvement of postoperative local treatment of patients with phlegmonous and necrotic forms of erysipelas allowed to significantly reduce the length of stay of patients in the hospital by 3,26 ± 0,43 days (t = 6,47461; P < 0,000001).
References
Gopaca GV, Ermakova LA. Rozha: sovremennoe sostojanie problemy. Nauchnyj al'manah.2016; 1–2; 364–366.
Lipatov KV, Komarova EA, Gur'janov RA. Diagnostika i hirurgicheskoe lechenie streptokokkovoj nekrotizirujushhej infekcii mjagkih tkanej. Rany i ranevye infekcii. 2015; 1: 6–12.
Cardona AF, Wilson SE. Skin and soft- tissue infections: a critical review and the role of telavancin in their treatment. Clinical Infectious Diseases. 2015; 61: 69–78.
Ferretti JJ, Stevens DL, Fischetti VA. Streptococcus pyogenes: Basic biology to clinical manifestations.(Electronic resource). Oklahoma City: University of Oklahoma Health Sciences Center. 2016. http://www.ncbi.nlm.nih.gov/ books/NBK333408.
Bruun T et al. Early response in cellulitis: a prospective study of dynamics and predictors Clinical Infectious Diseases. 2016; 63 (8): 1034–1041. doi: 10.1093/cid/ciw463.
Inghammar М, Rasmussen М, Linder A. Recurrent erysipelas – risk factors and clinical presentation . BMC Infect. Dis. 2014; 14: 270–274. doi: 10.1186/1471-2334-14-270.
Pasternak MS. Cellulitis, necrotizing fasciitis, and subcutaneous tissue infections. Principles and Practice of Infectious Diseases. – 8-th ed. – Philadelphia: Elsevier Saunders. 2015; 1194–2015. https://www.infectiousdiseaseadvisor.com.
Shapoval SD, Vasilevska LA. Seems of microorganisms in sick people on madness. Art of Medicine.2021; 2 (18): 140–143. https:// art-of-medicine.ifnmu.edu.ua › download.
